Diabetes joint with Obesity and Adipose Tissue Biology Organizer(s): Jiandie Lin, Clay F. Semenkovich and Rohit N. Kulkarni Date: January 22 - 26, 2017
Location: Keystone Resort, Keystone, CO, USADiabetes has reached alarming proportions worldwide, and the need for new therapies is great. Exercise and bariatric surgery are known to elicit profound metabolic benefits in type 2 diabetes, although the underlying mechanisms remain unclear. The possibility of altering metabolism through RNA-based therapies is also intriguing. This conference will bring together a diverse array of scientists from academia and industry, thereby facilitating knowledge exchange and interactions, leading to elucidation of better treatments. Joint sessions with the simultaneous conference on “Obesity and Adipose Tissue Biology” will create opportunities for synergies. Specifically, the conference will examine recent advances in understanding of brown/beige adipose tissue function; endocrine, paracrine and nutrient signaling; molecular mechanisms of metabolic signaling; emerging topics, including long noncoding RNA and the influence of the gut microbiome; and new approaches to drug development for treating diabetes and obesity. Global Health Travel Award Deadline: August 23 2016 Scholarship Deadline: September 22 2016 Discounted Abstract Deadline: September 22 2016 Abstract Deadline: October 25 2016 Discounted Registration Deadline: November 22 2016 We gratefully acknowledge additional support for this conference from:  We gratefully acknowledge the generous grant for this conference provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Grant No. 5R13DK104616-02 The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Grant No. 5R13DK104616-03 Funding for this conference was made possible (in part) by 5R13DK104616-03 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |